Yongho Na

Title: Yongho Na: Innovator in CCR2 Antagonist Compounds

Introduction

Yongho Na is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors in the body.

Latest Patents

Yongho Na holds a patent for "Piperazinyl 3-aminopyrrolidine derivatives as CCR2 antagonists." This invention relates to compounds that exhibit CCR2 (chemokine receptor 2) antagonistic effects, which are crucial for treating, preventing, or alleviating conditions such as rheumatoid arthritis, arteriosclerosis, multiple sclerosis, asthma, and other diseases associated with CCR2. The compounds described in the patent include various salts and isomers, providing a versatile approach to therapeutic applications.

Career Highlights

Throughout his career, Yongho Na has worked with reputable companies in the pharmaceutical industry. He has been associated with Yang Ji Chemical Co., Ltd. and Han Wha Pharma Co., Ltd., where he has contributed to research and development efforts in drug formulation and innovation.

Collaborations

Yongho Na has collaborated with several professionals in his field, including Jee Woong Lim and Jong-Hoon Kim. These collaborations have likely enhanced his research capabilities and contributed to the successful development of his patented compounds.

Conclusion

Yongho Na's work in developing CCR2 antagonists showcases his commitment to advancing medical science and improving treatment options for various diseases. His contributions to the field are significant and reflect the importance of innovation in healthcare.